FREEMAN KEVIN D - Insider Non-Derivative Transactions at GALECTIN THERAPEUTICS INC (GALT) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 23, 2025, FREEMAN KEVIN D's relationship to GALECTIN THERAPEUTICS INC (GALT) is Director, and currently has 55,269 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other GALT insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

FREEMAN KEVIN D - Insider Non-Derivative Transactions of GALT Common Stock

FREEMAN KEVIN D - Insider Non-Derivative Transactions at GALT

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 24, 2025	P -- (Common Stock)	5500	3.55	55269
Jul 18, 2025	P -- (Common Stock)	5000	2.9	49769
Dec 25, 2024	P -- (Common Stock)	10000	0.81	44769
Oct 18, 2024	P -- (Common Stock)	1300	2.64	34769
Oct 17, 2024	P -- (Common Stock)	5000	2.7	33469
Oct 17, 2024	P -- (Common Stock)	5000	2.7	80000
Jun 21, 2024	P -- (Common Stock)	2500	2.38	28469
Apr 23, 2024	P -- (Common Stock)	2500	2.98	25969
Apr 10, 2024	W -- (Common Stock)	2063	0	18063